Drug
Beclomethasone Dipropionate For Nebulisation
Beclomethasone Dipropionate For Nebulisation: highest development phase Phase 3, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| beclomethasone dipropionate suspension for nebulisation 800 mcg/2 ml NCT00938353 | Phase 3 | Croup |
Latest
No recent events.
Follow Beclomethasone Dipropionate For Nebulisation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.